Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Neuropsychological (NP) dysfunction has been linked to poor medication adherence among HIV-infected adults. However, there is a dearth of research examining longitudinal changes in the relationship between NP status and adherence rates. We hypothesized that declines in NP functioning would be associated with a corresponding decline in medication adherence while stable NP functioning would be associated with stable or improving adherence rates. Participants included 215 HIV-infected adults who underwent cognitive testing at study entry and six months later. Compared to the NP stable group, the NP decline group showed a greater drop in adherence rates. Further analysis revealed that, beyond global NP, learning and memory was significantly associated with changes in adherence rates. These findings further support the link between cognitive functioning and medication adherence and illustrates the importance of documenting changes in cognitive abilities for identifying individuals at risk for poor adherence.
- Karon JM, Dondero TJ, Curran JW. The projected incidence of AIDS and estimated prevalence of HIV infection in the United States. J Acquir Immune Defic Syndr. 1988;1(6):542–50.
- Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Adolescent medicine HIV/AIDS research network. Antiretroviral medication adherence among the reach HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27–40. CrossRef
- Casado JL, Sabido R, Perez-Elías MJ, et al. Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients. Antivir Ther. 1999;4(3):157–61.
- Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials. 2007;8:282–92. CrossRef
- Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16:2175–82. CrossRef
- Bangsberg DR, Hecht FM, Charlesbois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development off drug resistance in an indigent population. AIDS. 2000;14:357–66. CrossRef
- Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
- Murphy EL, Collier AC, Kalish KA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17–26.
- Nieuwkerk PT, Gisolf EH, Reijers MHE, Lange JMA, Danner SA, Sprangers MAG. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS. 2001;15:1985–91. CrossRef
- Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185–94. CrossRef
- Perno CF, Ceccherini-Silberstein F, De Luca A, et al. Virologic correlates of adherence to antiretroviral medications and therapeutic failure. J Acquir Immune Defic Syndr. 2002;31(3):S118–22.
- Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339–47. CrossRef
- Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175–83. CrossRef
- Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS. 1993;7:519–24. CrossRef
- Heaton RK, Grant I, Butters N, et al. The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J Int Neuropsychol Soc. 1995;1(3):231–51. CrossRef
- Hinkin CH, van Gorp WG, Satz P. Neuropsychological aspects of HIV infection. In: Kaplan HI, Saddock BJ, editors. The comprehensive textbook of psychiatry, vol. VI. Oxford: Blackwell; 1995.
- Miller EN, Seines OA, McArthur JC, et al. Neuropsychological performance in HIV-1-infected homosexual men: the multicenter aids cohort study (MACS). Neurology. 1990;40:197–203.
- Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9. CrossRef
- Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV + adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944–50.
- Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:19–25. CrossRef
- Levine A, Hinkin C, Castellon S, Mason K, Lam M, Perkins A. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;9:355–62. CrossRef
- Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead–Reitan battery: demographic corrections, research findings, and clinical applications. Odessa: Psychological Assessment Resources; 1991.
- Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-II-R (SCID). I: History, rationale, and description. Arch. Gen Psychiatry. 1992;49(8):624–9.
- Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307–19. CrossRef
- Lovejoy TI, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med. 2009;32(5):389–405. CrossRef
- Contardo C, Black AC, Beauvais J, Dieckhaus K, Rosen MI. Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol. 2009;24:547–54. CrossRef
- Woods SP, Iudicello JE, Moran LM, et al. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22:110–7. CrossRef
- Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults
AIDS and Behavior
Volume 15, Issue 8 , pp 1888-1894
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Medication adherence
- Cognitive decline
- Industry Sectors
- Author Affiliations
- 1. Neuropsychology Lab (256), VA Greater Los Angeles Health Care System, 11301 Wilshire, Boulevard, Los Angeles, CA, 90073, USA
- 2. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA